Texas Oncology - San Antonio

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Metastatic breast cancer2 trials
• Ovarian cancer2 trials

Phase

• Phase 35 trials
• Phase 2/31 trial

Status

• Recruiting4 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• Pfizer2 trials
• Tolmar Inc.2 trials
• Daiichi Sankyo1 trial
• Gilead Sciences1 trial

Running trials

• Recruiting

  T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

  NCT07683754· Phase 3· Daiichi Sankyo· Source

  Contact: Principal Investigator

• Recruiting

  Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

  NCT07226999· Phase 2/3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· Phase 3· Pfizer· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Gilead Sciences· Source

• Enrolling by invitation

  Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

  NCT05645536· Phase 3· Tolmar Inc.· Source

• Active, not recruiting

  Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

  NCT04906395· Phase 3· Tolmar Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Metastatic breast cancer2 recruiting
• Ovarian cancer1 recruiting